MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.
| Revenue (TTM) | $1.96B |
| Gross Profit (TTM) | $511.69M |
| EBITDA | $261.75M |
| Operating Margin | 14.20% |
| Return on Equity | 17.20% |
| Return on Assets | 6.86% |
| Revenue/Share (TTM) | $24.52 |
| Book Value | $11.16 |
| Price-to-Book | 2.93 |
| Price-to-Sales (TTM) | 1.25 |
| EV/Revenue | 1.365 |
| EV/EBITDA | 10.26 |
| Quarterly Earnings Growth (YoY) | -29.80% |
| Quarterly Revenue Growth (YoY) | 1.70% |
| Shares Outstanding | $78.13M |
| Float | $74.86M |
| % Insiders | 2.12% |
| % Institutions | 112.15% |
Volatility is currently expanding
Pediatrix Medical Group (MD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Pediatrix Medical Group NYSE: MD reported third-quarter 2026 adjusted EBITDA of $85 million, with management saying results exceeded its expectations despite rising costs across healthcare delivery. The company narrowed its full-year adjusted EBITDA outlook to a range of $290 million to $300 million.
Pediatrix Medical Group, Inc. ( MD ) Q3 2026 Earnings Call October 29, 2026 9:00 AM EDT Company Participants David Haddock - Executive Vice President, General Counsel & Secretary Mark Ordan - CEO & Executive Chairman Kasandra Rossi - Executive VP, Treasurer & CFO Conference Call Participants Matthew Mardula - William Blair & Company L.L.C., Research Division Albert Rice - UBS Investment Bank, Research Division Jack Slevin - Jefferies LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Pito Chickering - Deutsche Bank AG, Research Division Presentation Operator Hello, and thank you for standing by.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.67 per share a year ago.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MD and any ticker you trade — then tracks every position and per-strategy win rate.
